Results 41 to 50 of about 926 (181)

A systematic review to determine use of the Endometriosis Health Profiles to measure quality of life outcomes in women with endometriosis [PDF]

open access: yes, 2023
BACKGROUND The Endometriosis Health Profiles (EHPs), the EHP-30 and EHP-5, are patient-reported outcome measures that were developed to measure the health-related quality of life (HRQoL) of women living with endometriosis.
Budds, K   +7 more
core   +1 more source

Self-care interventions for sexual and reproductive health in humanitarian and fragile settings: a scoping review [PDF]

open access: yes, 2022
Background: Self-care is the ability of individuals, families, and communities to promote health, prevent disease, maintain health, and manage illness and disability with or without a health care provider.
Dawson, Angela   +2 more
core   +2 more sources

Contraceptive self-injection through routine service delivery: Experiences of Ugandan women in the public health system

open access: yesFrontiers in Global Women's Health, 2022
Contraceptive self-injection (SI) is a new self-care practice with potential to transform women's family planning access by putting a popular method, injectable contraception, directly into the hands of users.
Jane Cover   +5 more
doaj   +1 more source

Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis [PDF]

open access: yes, 2018
Introduction: Endometriosis is a chronic estrogen and progestogen responsive inflammatory disease associated with pain symptoms and infertility. The medical therapy of endometriosis aims to induce decidualization within the hormonally dependent ectopic ...
Barra, Fabio   +2 more
core   +1 more source

Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi [PDF]

open access: yesContraception, 2018
As low- and middle-income countries (LMICs) consider adding self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) to their contraceptive method mix, learning about family planning clients' and providers' experiences with self-injectable DMPA-SC during trials will inform introduction and scale-up efforts.We conducted ...
Holly M, Burke   +4 more
openaire   +2 more sources

Contraceptive self-injection through routine service delivery: Health worker perspectives from Uganda

open access: yesFrontiers in Global Women's Health, 2022
Self-care reproductive health innovations are increasingly valued as practices that enable women to manage their fertility with greater autonomy. While self-care, by definition, takes place beyond the clinic walls, many self-care practices nonetheless ...
Chloe Morozoff   +6 more
doaj   +1 more source

Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial

open access: yesThe Lancet Global Health, 2018
Summary: Background: Injectable contraceptives are popular in sub-Saharan Africa but have high discontinuation rates due partly to the need for provider-administered re-injection.
Holly M Burke, PhD   +7 more
doaj   +1 more source

Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries. [PDF]

open access: yesGlob Health Sci Pract, 2018
PATH partnered with the United Nations Population Fund (UNFPA) and country ministries of health (MOHs) to coordinate pilot introductions of subcutaneous depot medroxyprogesterone acetate (subcutaneous DMPA or DMPA-SC, brand name Sayana Press) in Burkina Faso, Niger, Senegal, and Uganda from July 2014 through June 2016 in order to expand the range of ...
Stout A   +5 more
europepmc   +4 more sources

Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi. [PDF]

open access: yesGlob Health Sci Pract, 2019
Evaluar los factores del lado de la oferta y la demanda que influyen en el uso continuado del anticonceptivo inyectable subcutáneo de depósito acetato de medroxiprogesterona (DMPA-SC). Llevamos a cabo un ensayo controlado aleatorizado de 12 meses en Malawi para medir las tasas de continuación de DMPA-SC.
Burke HM   +7 more
europepmc   +4 more sources

Home - About - Disclaimer - Privacy